Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinoma

European Journal of Surgical Oncology

Volumn 33, Issue 3, 2007, Pages 358-363

  Preuss, S F ^a   Klussmann, J P ^a   Wittekindt, C ^a   Damm, M ^a   Semrau, R ^a   Drebber, U ^a   Guntinas Lichius, O ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cervical lymph node metastases; Head and neck carcinoma; Multimodal treatment; Survival

Indexed keywords

CARBOPLATIN;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CERVICAL LYMPH NODE; CLINICAL PROTOCOL; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; LARYNX TUMOR; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; OROPHARYNX TUMOR; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33947612671     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.10.043     Document Type: Article

References (40)

1. Shah J.P. Cervical lymph node metastases-diagnostic, therapeutic and prognostic implications. Oncology 4 (1990) 61-69
2. Kalnins I.K., Leonard A.G., Sako K., Razak M.S., and Shedd D.P. Correlation between prognosis and degree of lymph node involvement in carcinoma of the oral cavity. Am J Surg 134 (1977) 450-454
3. O'Brien C.J., Smith J.W., Soung S.J., Urist M.M., and Maddox W.A. Neck dissection with and without radiotherapy: prognostic factors, patterns of recurrence and survival. Am J Surg 152 (1986) 456-463
4. Layland M.K., Sessions D.G., and Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 115 4 (2005 Apr) 629-639
5. Barkley Jr. H.T., Fletcher G.H., Jesse R.H., and Lindberg R.D. Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx and hypopharynx. Am J Surg 124 (1972) 462-467
6. Ellis E.R., Mendenhall W.M., Rao P.V., et al. Incisional or excisional neck node biopsy before definitive radiotherapy, alone or followed by neck dissection. Head Neck 13 (1991) 177-183
7. Mendenhall W.M., Million R.R., and Cassisi N.J. Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 12 (1986) 733-740
8. Narayan K., Crane C.H., Kleid S., Hughes P.G., and Peters L.J. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?. Head Neck 21 (1999) 606-613
9. Kramer S., Gelber R.D., Snow J.B., et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 10 (1987) 19-30
10. Mendenhall W.M., Villaret D.B., Amdur R.J., Hinerman R.W., and Mancuso A.A. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 24 (2002) 1012-1018
11. Cory J., Smith J.G., and Peters L.J. The concept of a planned neck dissection is obsolete. Cancer J 7 (2001) 472-474
12. Horiot J.C., Bontemps P., Van den Bogaert W., Le Fur R., et al. Accelerated fractionation compared to conventional fractionation improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 44 (1997) 111-121
13. Vokes E.E., Kies M.S., Haraf D.J., et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 18 8 (2000 Apr) 1652-1661
14. Garden A., Glisson B., Ang K., et al. A phase I/II trial of radiation with chemotherapy 'boost' for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J Clin Oncol 17 (1999) 2390-2395
15. Adelstein D.J., Li Y., Adams G.L., et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21 (2003) 92-98
16. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. Lancet 355 (2000) 949-955
17. Wendt T.G., Grabenbauer G.G., Rodel C.M., et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicentre study. J Clin Oncol 16 (1998) 1318-1324
18. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338 (1998) 1798-1804
19. Calais G., Alfonsi M., Bardet E., et al. Randomised trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst 91 (1999) 2081-2086
20. Adelstein D.J., Lavertu P., Saxton J.P., et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 88 (2000) 876-883
21. Jeremic B., Shibamoto Y., Milicic B., et al. Hyperfractionated radiation therapy with or without concurrent low dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomised trial. J Clin Oncol 18 (2000) 1458-1464
22. Agiris A. Update on chemoradiotherapy for head and neck cancer. Curr Opin Oncol 14 (2002) 323-329
23. Forastiere A.A., Berkey B., and Maor M. Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone, Intergroup trial R91-11. Proc Am Soc Clin Oncol 20 (2001) A4
24. UICC (International Union Against Cancer). TNM classification of malignant tumours. 5th ed. (1997), Wiley-Liss, New York
25. Isaacs Jr. J.H., and Schnitman J.R. Outcome of treatment of 160 patients with squamous cell carcinoma of the neck staged N3a. Head Neck 12 (1990) 483-487
26. Khafif R.A., Gelbfish G.A., Asase D.K., Tepper P., and Attle J.N. Modified radical neck dissection in cancer of the mouth, pharynx and larynx. Head Neck 12 (1990) 476-482
27. Ahmed K.A., Robbins K.T., Wong F., and Salazar J.E. Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma. Laryngoscope 110 11 (2000 Nov) 1789-1793
28. Cerezo L., Millan I., Torre A., Aragon G., and Otero J. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases. Cancer 69 5 (1992 Mar 1) 1224-1234
29. Recondo G., Cvitkovic E., Wibault P., et al. Neoadjuvant chemotherapy consisting of cisplatin and continuous infusions of bleomycin and 5-fluorouracil for advanced head and neck cancer. The need for a new stratification for stage IV (M0) disease. Cancer 68 10 (1991 Nov 15) 2109-2119
30. Clark J., Li W., Smith G., et al. Outcome of treatment for advanced cervical metastatic squamous cell carcinoma. Head Neck 27 2 (2005 Feb) 87-94
31. Mastronikolis N.S., Fitzgerald D., Owen C., Neary Z., Glaholm J., and Watkinson J.C. The management of squamous cell carcinoma of the neck. The Birmingham UK experience. Eur J Surg Oncol 31 5 (2005 Jun) 461-466 Epub 2005 Apr 19
32. Robson A. The management of the neck in squamous head and neck cancer. Clin Otolaryngol 26 (2001) 157-161
33. Ferlito A., Rinaldo A., Thomas Robbins K., et al. Changing concepts in the surgical management of the cervical node metastasis. Oral Oncol 39 (2003) 429-435
34. Sundaram K., Schwartz J., Har-El G., and Lucente F. Carcinoma of the oropharynx: factors affecting outcome. Laryngoscope 115 9 (2005 Sep) 1536-1542
35. Perez C.A., Patel M.M., Chao K.S., et al. Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome. Int J Radiat Oncol Biol Phys 42 5 (1998 Dec 1) 1077-1084
36. Preuss SF, Dinh V, Klussmann JP, Semrau R, Mueller RP, Guntinas-Lichius O. Outcome of multimodal treatment for oropharyngeal cancer: a single institution experience, Oral Oncol 2006 Oct 26 [Epub ahead of print].
37. Preuss SF, Quante G, Klussmann JP, Semrau R, Mueller RP, Guntinas-Lichius O. An analysis of surgical complications, morbidity and cost calculation in patients undergoing multimodal treatment for oropharyngeal carcinoma, Laryngoscope, in press.
38. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 22 (2003 Nov 27) 2091-2098
39. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 6 (2006 Feb 9) 567-578
40. Budach V., Stuschke M., Budach W., et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 23 6 (2005 Feb 20) 1125-1135